Cargando…

Diabetic retinopathy: reversibility of epigenetic modifications and new therapeutic targets

In recent years, considerable progress has been made in the molecular mechanisms of epigenetics in disease development and progression, the reversible characteristics of epigenetic modification provide new insights for the treatment of such diseases. The pathogenesis of diabetic retinopathy (DR) has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xinyuan, Zhao, Lin, Hambly, Brett, Bao, Shisan, Wang, Kaiyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557533/ https://www.ncbi.nlm.nih.gov/pubmed/28815013 http://dx.doi.org/10.1186/s13578-017-0167-1

Ejemplares similares

Reverse Cholesterol Transport Pathway and Cholesterol Efflux in Diabetic Retinopathy
por: Zhang, Xinyuan, et al.
Publicado: (2021)

Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy
por: Perrone, Lorena, et al.
Publicado: (2014)

Erratum to “Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy”
por: Perrone, Lorena, et al.
Publicado: (2014)

Epigenetic Modifications and Diabetic Retinopathy
por: Kowluru, Renu A., et al.
Publicado: (2013)

The role of IL-35 and IL-37 in breast cancer – potential therapeutic targets for precision medicine
por: Ma, Yuntao, et al.
Publicado: (2022)

The Epidemiology of COVID-19 in the Gansu and Jinlin Provinces, China
por: Fan, Jingchun, et al.
Publicado: (2020)

Epigenetic modification and therapeutic targets of diabetes mellitus
por: Singh, Rajveer, et al.
Publicado: (2020)

The epidemiology of reverse transmission of COVID-19 in Gansu Province, China
por: Fan, Jingchun, et al.
Publicado: (2020)

Epigenetic Modifications as Therapeutic Targets
por: Kelly, Theresa K, et al.
Publicado: (2010)

Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surface
por: Liu, Dan-Dan, et al.
Publicado: (2022)

Regulation of Matrix Metalloproteinase-9 by Epigenetic Modifications and the Development of Diabetic Retinopathy
por: Zhong, Qing, et al.
Publicado: (2013)

Epigenetic Modifications in Peripheral Blood as Potential Noninvasive Biomarker of Diabetic Retinopathy
por: Duraisamy, Arul J., et al.
Publicado: (2019)

Klotho: A new therapeutic target in diabetic retinopathy?
por: Puddu, Alessandra, et al.
Publicado: (2023)

Epigenetic Modifications Compromise Mitochondrial DNA Quality Control in the Development of Diabetic Retinopathy
por: Mohammad, Ghulam, et al.
Publicado: (2019)

Epigenetic modifications in pancreas development, diabetes, and therapeutics
por: Kaimala, Suneesh, et al.
Publicado: (2022)

The Role of IL-37 and IL-38 in Colorectal Cancer
por: Dang, Jie, et al.
Publicado: (2022)

Inverse correlation between Interleukin-34 and gastric cancer, a potential biomarker for prognosis
por: Liu, Qinghua, et al.
Publicado: (2020)

Proteomics identifies new potential therapeutic targets of diabetic retinopathy
por: Zhou, Huanran, et al.
Publicado: (2022)

Epigenetic modifications in hyperhomocysteinemia: potential role in diabetic retinopathy and age-related macular degeneration
por: Elmasry, Khaled, et al.
Publicado: (2018)

Epigenetic modification and inheritance in sexual reversal of fish
por: Shao, Changwei, et al.
Publicado: (2014)

Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19
por: Law, Ching Chee, et al.
Publicado: (2021)

Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy
por: Popescu, Mihaela, et al.
Publicado: (2018)

Diabetic Retinopathy and Inflammation: Novel Therapeutic Targets
por: Rangasamy, Sampathkumar, et al.
Publicado: (2012)

ROCK as a Therapeutic Target of Diabetic Retinopathy
por: Arita, Ryoichi, et al.
Publicado: (2010)

Neuroprotection as a Therapeutic Target for Diabetic Retinopathy
por: Hernández, Cristina, et al.
Publicado: (2016)

Genome-wide DNA methylation analysis of extreme phenotypes in the identification of novel epigenetic modifications in diabetic retinopathy
por: Yang, Shaopeng, et al.
Publicado: (2022)

The Hippo signaling pathway: a potential therapeutic target is reversed by a Chinese patent drug in rats with diabetic retinopathy
por: Hao, Gai-mei, et al.
Publicado: (2017)

Cross-Sectional Study on Health Literacy and Internet Accessibility Among Patients With DM in Gansu, China
por: Zhao, Na, et al.
Publicado: (2021)

IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
por: Chen, Feier, et al.
Publicado: (2020)

The outcomes of lockdown in the higher education sector during the COVID-19 pandemic
por: Cai, Peiling, et al.
Publicado: (2023)

The impact of COVID-19 lockdown on nursing higher education at Chengdu University
por: Cai, Peiling, et al.
Publicado: (2023)

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
por: Esposito, Michelle, et al.
Publicado: (2019)

Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets
por: Shu, Feng, et al.
Publicado: (2023)

Epigenetics and Regulation of Oxidative Stress in Diabetic Retinopathy
por: Duraisamy, Arul J., et al.
Publicado: (2018)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

Molecular Mechanisms of Diabetic Retinopathy: Potential Therapeutic Targets
por: Coucha, Maha, et al.
Publicado: (2015)

Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
por: Parveen, Amna, et al.
Publicado: (2018)

Epigenetic modifications and diabetic nephropathy
por: Reddy, Marpadga A., et al.
Publicado: (2012)

Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy
por: Agardh, Elisabet, et al.
Publicado: (2015)

Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies
por: Vähätupa, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pno4j6kcnj78u5lh7l4lfcl01h